Browsing by Author Irish, Ashley

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2014A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infectionGracey, David; Abbas, Riaz; Baer, Richard; Boyd, Mark; Holt, Stephen G; Irish, Ashley; Levy, Miriam; Mudge, David; Sevastos, Jacob; Walker, Rowan G; Central Clinical School: MedicineA consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection, AIDS Research and Therapy, vol.11, N/A, 2014,pp 1-10
2002Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemiaHarris, David; Pollock, Carol; Collins, John; Disney, Alex; Hawley, Carmel; Irish, Ashley; Kerr, Peter; Lynn, Kelvin; Makris, Angela; Roger, Simon; Walker, Rob; Walker, Rowan; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: MedicineDarbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia, Nephrology, vol.7,(6),2002,pp S173-S180
2017Impact of early conversion from cyclosporin to everolimus on left ventricular mass index: A randomized controlled trialTeixeira-Pinto, Armando Rogerio; Wong, Germaine; Boudville, Neil; Chakera, Aron; Chan, Doris; Dogra, Gursharan; Irish, Ashley; Krishnan, Anoushka R; Lim, Wai H; Morgan, Kelly; Phillips, Jessica; School of Public Health: Public Health; School of Public Health: Public HealthImpact of early conversion from cyclosporin to everolimus on left ventricular mass index: A randomized controlled trial, Clinical Transplantation, vol.31, 10, 2017,pp 1-9
2014Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized PatientsCraig, Jonathan; Howard, Kirsten; Wong, Germaine; Chapman, Jeremy R; Christiansen, F.; Claas, Frans H J; D'Orsogna, Lloyd; Ferrari, Paolo; Fidler, Samantha; Irish, Ashley; Lim, Wai; Nguyen, Hung Do; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public HealthModeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients, Transplantation, vol.97, 7, 2014,pp 769-774
2009Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyCass, Alan; Heritier, Stephane; Beller, Elaine; Dogra, Gursharan; Hawley, Carmel; Irish, Ashley; Kerr, Peter G.; Mori, Trevor A; Paul-Brent, Peta-Anne; Polkinghorne, Kevan R.; Robertson, Amanda; Rosman, Johan; Starfield, Melissa; School of Public Health: Medicine; The George Institute for Global HealthPreventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study, BMC Nephrology, vol.10, 1, 2009,pp 1-1-1-12
2003Recommendations for the use of icodextrin in peritoneal dialysis patientsHarris, David; Ibels, Lloyd; AGAR, JOHN; Collins, John; DISNEY, ALEX; Irish, Ashley; Johnson, David W; SALTISSI, DAVID; Suranyi, Michael; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: MedicineRecommendations for the use of icodextrin in peritoneal dialysis patients, Nephrology, vol.8,(1),2003,pp 1-7